Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
ELAHERE Inf Konz 100 mg/20ml Durchstf 20 ml
Drug
ELAHERE, Konzentrat zur Herstellung einer Infusionslösung
Ovarial-, Tuben- oder primäres Peritonealkarzinom
07.16.1. – cytostatics
HAM – Human medicine
KOINF – Concentrate for solution for infusion
BT – biological medicines
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
3/13/2025
3/12/2030
Dosage strength
ELAHERE 100 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung
Ovarial-, Tuben- oder primäres Peritonealkarzinom
01
Z – approved
Package
7680697000014
In trade from / since 3/13/2025
A/R – Authorised / referenced
1 vial(s)
001
Z – approved
Declaration
Component
100 mg mirvetuximabum soravtansinum
acidum aceticum
polysorbatum 20
natrii acetas
2.94 mg natrium
saccharum
aqua ad iniectabile
polysorbatum 20
natrii acetas
2.94 mg natrium
saccharum
aqua ad iniectabile
Authorisation holder
7601001396968
AbbVie AG
Alte Steinhauserstrasse 14
6330 Cham (ZG)
Alte Steinhauserstrasse 14
6330 Cham (ZG)
Date of revision of the text
4/29/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.